Taltz Archives -

Stockpiling of drugs for chronic diseases like diabetes during the coronavirus pandemic lifted Eli Lilly’s first-quarter results, and

Lilly raises 2020 earnings forecast on pandemic stockpiling

https://pharmaphorum.com/news/lilly-raises-2020-earnings-forecast-on-pandemic-stockpiling/

Beating AbbVie’s TNF blocker Humira in a head-to-head trial has become a rite of passage for new interleukin-targeting

Novartis’ Cosentyx didn’t EXCEED Humira in psoriatic arthritis

https://pharmaphorum.com/news/novartis-cosentyx-cant-exceed-humira-in-psoriatic-arthritis/

Christi Shaw, president of Eli Lilly Bio-Medicines is leaving the company after two years, taking the top job

Lilly dips as biomed chief Christi Shaw heads to Gilead

https://pharmaphorum.com/news/lilly-dips-as-biomed-chief-christi-shaw-heads-to-gilead/

Eli Lilly’s Taltz has beaten AbbVie’s blockbuster Humira in a psoriatic arthritis study involving patients who hadn’t been

Lilly’s Taltz scrapes win against Humira in psoriatic arthritis

https://pharmaphorum.com/news/lillys-taltz-scrapes-win-against-humira-in-psoriatic-arthritis/

Taltz